The bone marrow of the axial skeleton is the preferred site of metastases in the large majority of patients with prostate cancer. The striking selectivity has been viewed as an example of site-specific cell-cell interactions that are essential to prostate cancer progression. Despite the obvious clinical relevance, little is known about the mechanisms that control prostate cancer metastasis. In addition, there are no effective strategies for targeting therapeutic agents for the treatment of metastatic prostate cancer. Here, we propose to select peptides that home to bone marrow and to prostate cancer bone metastasis. Phage peptides libraries will be screened in vivo and ex-vivo. In vivo phage display technology has been developed and used successfully to target several organs and tumors and generate probes with selective homing capabilities. We will select and characterize bone marrow and prostate cancer bone metastases- homing peptides; such peptides will be used to target therapies against metastatic prostate cancer and in understanding the mechanisms that control prostate cancer metastasis. We will then identify the receptors for the peptide ligands using biochemical and genetic methods. Finally, we will test the effects of targeted therapies in prostate cancer bone metastases. Two classes of receptors known to be up-regulated in angiogenic vasculature will be targeted, metalloproteases and aminopeptidases. Extensive previous work shows that these receptors are not accessible in the vasculature of normal organs and that the inhibition of such proteases leads to tumor regression. Novel therapeutic strategies to inhibit prostate cancer metastatic spread to bone marrow will derive from this work. Peptides that target prostate cancer bone metastases will be developed as delivery tools and will likely enhance effectiveness of existing therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA090270-01
Application #
6466081
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-06-01
Project End
2006-12-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Salameh, Ahmad; Lee, Alessandro K; Cardó-Vila, Marina et al. (2015) PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A 112:8403-8
Pasqualini, Renata; Millikan, Randall E; Christianson, Dawn R et al. (2015) Targeting the interleukin-11 receptor ? in metastatic prostate cancer: A first-in-man study. Cancer 121:2411-21
Euscher, Elizabeth; Fox, Patricia; Bassett, Roland et al. (2013) The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol 37:1728-36
Efstathiou, Eleni; Karlou, Maria; Wen, Sijin et al. (2013) Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate 73:153-61
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2012) Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. Am J Mens Health 6:249-57
Heymach, John V; Shackleford, Terry J; Tran, Hai T et al. (2011) Effect of low-fat diets on plasma levels of NF-?B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila) 4:1590-8
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2011) Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Cent Eur J Public Health 19:30-4
Kadowaki, Yoshihiko; Chari, Nikhil S; Teo, Albert E K et al. (2011) PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells. Apoptosis 16:627-35
Efstathiou, Eleni; Abrahams, Neil A; Tibbs, Rita F et al. (2010) Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur Urol 57:1030-8
Ravoori, Murali; Czaplinska, Aneta J; Sikes, Charles et al. (2010) Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5:e9854

Showing the most recent 10 out of 153 publications